LIQUID-REPELLENT COMPOSITION, METHOD FOR TREATING SUBSTRATE, AND ARTICLE

    公开(公告)号:US20230407107A1

    公开(公告)日:2023-12-21

    申请号:US18461085

    申请日:2023-09-05

    Applicant: AGC Inc.

    CPC classification number: C09D5/1668 C09D7/63 B05D5/08

    Abstract: The present invention relates to a liquid-repellent composition which is hydrocarbon-based and can impart excellent liquid repellency; a method for treating a substrate using the liquid-repellent composition; and an article equipped with a coating film which is hydrocarbon-based and has excellent liquid repellency. The liquid-repellent composition of the present invention comprises a polymer (A) having a unit based on the following monomer (a); in the method for treating a substrate of the present invention, a substrate is treated with the liquid-repellent composition of the present invention; and the article of the present invention has a substrate treated with the liquid-repellent composition of the present invention. Formula (a) is (R1—Q1—)HC═CH(—Q2—R2). Q1 and Q2 each independently a divalent linking group. R1 and R2 each independently a monovalent hydrocarbon group having 8 to 24 carbon atoms.

    CELL CULTURE CONTAINER
    4.
    发明申请

    公开(公告)号:US20200299626A1

    公开(公告)日:2020-09-24

    申请号:US16895485

    申请日:2020-06-08

    Applicant: AGC Inc.

    Abstract: To provide a cell culture container capable of preparing spheroids having a uniform size highly efficiently, and capable of microscopic observation simply, particularly fluorescence microscopic observation.A cell culture container comprising: side walls forming an opening, a bottom comprising a light-transmitting glass material, closing the lower end of the opening and having a plurality of recesses in a region which the opening faces on its upper surface, and a surface layer inhibiting cell adhesion formed on the inner surface of the recesses.

    MEDICAL DEVICE
    5.
    发明申请

    公开(公告)号:US20250041491A1

    公开(公告)日:2025-02-06

    申请号:US18903062

    申请日:2024-10-01

    Applicant: AGC Inc.

    Abstract: A medical device where the non-specific absorption amount is reduced, durability is excellent, and eluents from the surface layer are reduced. The medical device includes a device substrate and a surface layer provided on at least part of the surface of the device substrate in contact with water, where the part of the surface of the device substrate is made of an inorganic material, the surface layer is made of a cured product of a compound having a biocompatible group and an alkoxysilyl group, the content of the biocompatible group in the compound is from 25 to 83% by mass, and the content of the alkoxysilyl group is from 2 to 70% by mass.

    COPOLYMER, COMPOSITION, AND ARTICLE

    公开(公告)号:US20240400737A1

    公开(公告)日:2024-12-05

    申请号:US18805628

    申请日:2024-08-15

    Applicant: AGC Inc.

    Abstract: A copolymer having a unit (A) having a reactive silyl group, a unit (B) having a group represented by formula (1) shown below, and a unit (C) represented by formula (2) shown below. In the formulas, n1 represents 2 or 3, and n2 represents an integer of 0 to 300, n3 represents 2 or 3, n4 represents an integer of 0 to 300, R6 represents an alkyl group, and the ratio represented by (n4+1)/(number of carbon atoms in R6) is at least 0.5 but less than 9.

    ABA TRIBLOCK POLYMER, COMPOSITION, SURFACE TREATMENT AGENT, ARTICLE, AND METHOD FOR MANUFACTURING ARTICLE

    公开(公告)号:US20250026950A1

    公开(公告)日:2025-01-23

    申请号:US18899284

    申请日:2024-09-27

    Applicant: AGC INC.

    Abstract: An ABA triblock polymer, in which an A block is a random polymer including a constituent unit derived from a reactive group-containing polymerizable monomer and a constituent unit derived from a reactive group-free polymerizable monomer, a B block contains a polyalkylene oxide chain or a divalent organopolysiloxane residue in a main chain, the constituent unit derived from a reactive group-free polymerizable monomer contains a constituent unit derived from a hydrophobic group-containing polymerizable monomer in a case in which the B block contains a polyalkylene oxide chain in a main chain, and the constituent unit derived from a reactive group-free polymerizable monomer contains a constituent unit derived from a hydrophilic group-containing polymerizable monomer in a case in which the B block contains a divalent organopolysiloxane residue in a main chain, as well as applications thereof. The details of the reactive group, the hydrophobic group, and hydrophilic group are omitted.

    PROTEIN ADHESION INHIBITOR, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND ARTICLE

    公开(公告)号:US20190077966A1

    公开(公告)日:2019-03-14

    申请号:US16188358

    申请日:2018-11-13

    Applicant: AGC Inc.

    Abstract: To provide a protein adhesion inhibitor from which a cured product having excellent protein non-adhesion and having excellent form stability so that a film formed therefrom will not warp, can be formed, a cured product using it, and an article.A protein adhesion inhibitor comprising a non-polymerizable fluorinated polymer having a specific group such as —(CnH2nO)— and a fluorine atom content QF of from 5 to 60 mass %, and at least one curable monomer selected from the group consisting of a vinyl monomer and a cyclic ether monomer, wherein the coefficient α is at most 10. A cured product of the protein adhesion inhibitor. A medical device 1 comprising a substrate 2 and a coating layer 3 formed of the cured product of the protein adhesion inhibitor on the substrate 2.

Patent Agency Ranking